JOHNSON & JOHNSON is 415.7x more valuable than ATAI Life Sciences N.V. by market capitalization ($573.71 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | JNJ |
|---|---|---|
| Market cap | $1.38 B | $573.71 B |
| US-listed rank | #2408 | #20 |
| Revenue (latest FY) | $308.00K | $94.19B |
| Net income (latest FY) | -$149.27M | $26.80B |
| Net margin | -48464.0% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 320 | 984 |
JOHNSON & JOHNSON is 415.7x more valuable than ATAI Life Sciences N.V. by market capitalization ($573.71 B vs $1.38 B).
In their latest fiscal years, ATAI Life Sciences N.V. reported $308.00K in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: ATAI Life Sciences N.V. and JOHNSON & JOHNSON, or browse the full rankings.